GILD CIK: 882095

Gilead Sciences Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
20.7
FY22:
21.6
FY23:
20.6
FY24:
22.5
FY25:
23.2
(positive)
Change from FY21 to FY25
billions USD
FY21:
9.92
FY22:
7.33
FY23:
7.61
FY24:
1.66
FY25:
10.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.28
FY22:
5.81
FY23:
6.86
FY24:
0.69
FY25:
9.80
(positive)
Change from FY21 to FY25
billions USD
FY21:
6.23
FY22:
4.59
FY23:
5.67
FY24:
0.48
FY25:
8.51

All amounts in billions USD Data source:SEC EDGAR